NEOGAP Therapeutics

About:

NEOGAP Therapeutics is a Pharmaceutical manufacturing industry.

Top Investors: European Innovation Council, Sciety, Eurostars, Sciety Venture Partners, 3T Invest

Description:

NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.

Total Funding Amount:

$19.7M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Stockholm, Stockholms Lan, Sweden

Founded Date:

2016-01-01

Contact Email:

Samuel.svensson(AT)neogap.se

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-03-26

IPO Status:

Private

Industries: